4//SEC Filing
JEFFS ROGER 4
Accession 0001231615-25-000004
CIK 0001579428other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 7:00 PM ET
Size
6.4 KB
Accession
0001231615-25-000004
Insider Transaction Report
Form 4
JEFFS ROGER
Director
Transactions
- Sale
Common Stock
2025-08-26$120.03/sh−20,000$2,400,600→ 130,974 total - Sale
Common Stock
2025-08-22$120.08/sh−16,694$2,004,616→ 150,974 total
Footnotes (4)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.34.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.26.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001231615
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 7:00 PM ET
- Size
- 6.4 KB